In vivo Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer’s Disease

/by

Authors: Georgia Watt, Tim Karl
Frontiers in Pharmacology, 3 February 2017
—
Alzheimer’s disease (AD) is a debilitating neurodegenerative disease that is affecting an increasing number of people. It is characterized by the accumulation of amyloid-β and tau hyperphosphorylation as well as neuroinflammation and oxidative stress. Current AD treatments do…

Read more

Cannabinoids in Parkinson’s Disease.

/by

Authors: Mario Stampanoni Bassi, Andrea Sancesario, Roberta Morace, Diego Centonze, Ennio Iezzi
Cannabis and Cannabinoid Research, February 2017
—
The endocannabinoid system plays a regulatory role in a number of physiological processes and has been found altered in different pathological conditions, including movement disorders. The interactions between cannabinoids and dopamine in the basal ganglia are remarkably compl…

Read more